Planning for Covid Vaccines and Costs – Bloomberg
Article summary
Planning for Covid Vaccines and Costs By December 4, 2020, 7:29 AM EST SHARE THIS ARTICLE Here’s the latest news from the global pandemic. Glaxo-backed Stimulus optimism grows as GOP warms to bipartisan plan Germany to extend $37 billion backstop for credit insurers Planning for Covid vaccines and costs The dream of Covid-19 vaccines is coming closer to reality as Operation Warp Speed officials said that U.S. states’ plans to roll out a shot from Pfizer are due Friday. The U.S. is ready to ship 6.4 million doses of the vaccine from Pfizer and partner BioNTech as soon as the Food and Drug Administration clears it, said Gus Perna, chief operations officer of the federal drugs and vaccines accelerator. U.K. drug regulators have already cleared it . Meanwhile, U.S. employers are increasingly concerned about their share of treatment costs for hospitalized Covid patients who currently number more than 100,000. […] Employers are also concerned about prices for vaccines, many of which have been developed with taxpayer funds allocated through Operation Warp Speed .
